Lippa Arnold

CIK 00013637633 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001363763

Recent Transactions

39 trades

Award
Hepion Pharmaceuticals, Inc.$HEPA
Stock Options
2021-05-18+200,000→ 291,110 total
Gift
RespireRx Pharmaceuticals Inc.
Series H Preferred Stock
2020-09-30+100→ 0 total
Gift
RespireRx Pharmaceuticals Inc.
Series H Preferred Stock
2020-09-30−100→ 0 total
Other
RespireRx Pharmaceuticals Inc.
Series H Preferred Stock
2020-09-30+100→ 100 total
Award
Hepion Pharmaceuticals, Inc.$HEPA
Stock Options
2020-08-19+30,000→ 91,110 total
Other
RespireRx Pharmaceuticals Inc.
Series H Preferred Stock
2020-07-13+600→ 600 total
Gift
RespireRx Pharmaceuticals Inc.
Series H Preferred Stock
2020-07-13−600→ 0 total
Gift
RespireRx Pharmaceuticals Inc.
Series H Preferred Stock
2020-07-13+600→ 0 total
Award
Hepion Pharmaceuticals, Inc.$HEPA
Stock Options
2020-04-03+60,000→ 61,109 total
Gift
RespireRx Pharmaceuticals Inc.
Common Stock
2020-03-22−4,500,000→ 598 total
Other
RespireRx Pharmaceuticals Inc.
Common Stock
2020-03-22+4,500,000→ 4,500,598 total
Award
Hepion Pharmaceuticals, Inc.$HEPA
Stock Options
2019-07-24+970→ 1,109 total
Purchase
RespireRx Pharmaceuticals Inc.
Common Stock
2018-09-12+47,620→ 47,620 total
Purchase
RespireRx Pharmaceuticals Inc.
Common Stock Warrants (right to buy)
2018-09-12+47,620→ 47,620 total
Gift
RespireRx Pharmaceuticals Inc.
Common stock Warrants (right to buy)
2018-09-12−47,620→ 0 total
Gift
RespireRx Pharmaceuticals Inc.
Common stock
2018-09-12−47,620→ 0 total
Purchase
Hepion Pharmaceuticals, Inc.$HEPA
Series C Convertible Preferred Stock
2018-07-03$1000.00/sh+15→ 15 total
Purchase
Hepion Pharmaceuticals, Inc.$HEPA
Warrants
2018-07-03$1000.00/sh+8,625→ 8,625 total
Other
RespireRx Pharmaceuticals Inc.
Common Stock Options (to purchase shares of Common Stock)
2017-12-09+559,595→ 559,595 total
Gift
RespireRx Pharmaceuticals Inc.
Common Stock Options (to purchase shares of Common Stock)
2017-12-09−559,595→ 0 total
Other
RespireRx Pharmaceuticals Inc.
Common Stock Options (to purchase shares of Common Stock)
2017-06-30−50,000→ 0 total
Award
RespireRx Pharmaceuticals Inc.
Common Stock Options (to purchase shares of Common Stock)
2017-06-30+50,000→ 50,000 total
Other
RespireRx Pharmaceuticals Inc.
Common Stock Options (to purchase shares of Common Stock)
2017-01-18−50,000→ 0 total
Award
RespireRx Pharmaceuticals Inc.
Common Stock Options (to purchase shares of Common Stock)
2017-01-18+50,000→ 50,000 total
Award
Hepion Pharmaceuticals, Inc.$HEPA
Stock Options
2016-07-19+32,500→ 77,500 total
Other
RespireRx Pharmaceuticals Inc.
Common Stock Options (to purchase shares of Common Stock)
2016-06-16−24,000,000→ 0 total
Other
RespireRx Pharmaceuticals Inc.
Common Stock Options (to purchase shares of Common Stock)
2016-06-16−10,000,000→ 0 total
Other
RespireRx Pharmaceuticals Inc.
Common Stock Options (to purchase shares of Common Stock)
2016-06-16−15,000,000→ 0 total
Award
RespireRx Pharmaceuticals Inc.
Common Stock Options (to purchase shares of Common Stock)
2016-03-31+24,000,000→ 24,000,000 total
Other
RespireRx Pharmaceuticals Inc.
Common Stock Warrants (right to buy)
2016-01-29+3,350,319→ 3,350,319 total
Award
RespireRx Pharmaceuticals Inc.
Common Stock Options (to purchase shares of Common Stock)
2015-08-18+10,000,000→ 10,000,000 total
Award
RespireRx Pharmaceuticals Inc.
Common Stock Options (to purchase shares of Common Stock)
2015-06-30+15,000,000→ 15,000,000 total
Award
RespireRx Pharmaceuticals Inc.
Common Stock Options (to purchase shares of Common Stock)
2014-07-17+5,000,000→ 5,000,000 total
Purchase
RespireRx Pharmaceuticals Inc.
Series G 1.5% Convertible Preferred Stock
2014-03-18$1000.00/sh+250→ 250 total
Disposition to Issuer
Euthymics Bioscience, Inc.
Stock Option (right to buy)
2008-05-16−407,600→ 387,000 total
Award
Euthymics Bioscience, Inc.
Stock Option (right to buy)
2008-05-16$0.05/sh+260,000→ 387,000 total
Award
Euthymics Bioscience, Inc.
Stock Option (right to buy)
2008-05-16$0.10/sh+127,000→ 387,000 total
Award
Euthymics Bioscience, Inc.
Stock Option (right to buy)
2007-08-09+127,000→ 407,600 total
Award
Euthymics Bioscience, Inc.
Restricted Stock Units
2007-08-09+100,000→ 100,000 total

Companies

Recent Filings

Address

C/O AURORA CAPITAL, LLC 17 PARK AVENUE, #201

NEW YORK, NY, 10016

View on SEC.gov